UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000030551
Receipt number R000034877
Scientific Title Phase I study of nab-paclitaxel and gemcitabine chemoradiotherapy for borderline resectable and locally advanced unresectable pancreatic ductal adenocarcinoma
Date of disclosure of the study information 2017/12/25
Last modified on 2020/06/27 14:27:24

No. Disposal Last modified on Item of update
1 Insert 2017/12/25 02:51:12
2 Update 2018/02/16 00:56:11 Recruitment status
3 Update 2019/06/28 20:18:15 Date of IRB
Last follow-up date
4 Update 2019/06/28 22:08:08 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Email

Last name of contact person

Last name of contact person
Zip code
Email3
Organization
Organization
Address
Address
Tel
Email
5 Update 2020/06/27 14:21:22 Recruitment status
Last follow-up date
6 Update 2020/06/27 14:25:42 Email1
Email3
Email
7 Update 2020/06/27 14:27:24 Number of participants that the trial has enrolled